Cytodyn Inc (CYDY)

[Scooter McCabe]

White Paper: "The Case For Removing Nader"

1. Nader constantly over promises and under delivers.

2. Major promotions of the company and drug have been because of shareholders reaching out to news organizations, not Nader.

3. Nader is well meaning but not a businessman.

4. Nader's ego does not allow him to stand aside and let more compelling people take the stage.

5. Nader spent too much time getting everyone into EINDs rather than enrolling them into the COVID study placing us behind in 8 ball in the COVID race.

6. Nader consistently misses deadlines reflecting poorly on his management skills.

7. Nader as CEO should be able to fend off bottom feeders like Adam Feuerstein but can't. As we step into the larger arenas we will face more dangerous opponents. Nader is not our champion.

8. Nader has not come close to the promised "10 trials this year" line in the sand goal he set.

9. Nader has failed to secure financing as promised.

10. Nader's removal may actually increase the price per share in favor of a CEO that can be taken seriously.

11. Nader has been begged by shareholders to stay on track and execute as promised and has consistently ignored good counsel or learned from previous mistakes.

12. Nader has needed the FDA to hold his hand on everything.

13. The FDA had to force Nader to actually go forward with the phase II COVID study.

14. Nader often appears not to understand the science behind the drug, sounds unsure of basic company knowledge which reflects in his poor presence in interviews.

15. Nader is a lighting rod for hit pieces and character assassination.